Ekso Bionics

Ekso Bionics is a pioneering robotics company based in Northern California that specializes in developing wearable exoskeletons and robotic-assist devices for various applications, including medical and industrial markets. With a focus on cutting-edge innovation, Ekso Bionics aims to address unique customer challenges in rehabilitation and empower individuals to overcome physical limitations. Their lightweight assist devices offer enhanced mobility, strength, and endurance, revolutionizing the way people approach physical tasks. Through strategic partnerships and a commitment to technological advancements, Ekso Bionics continues to lead the field of robotics. Ekso Bionics Holdings, Inc., listed under the symbol NASDAQ EKSO, is dedicated to commercializing wearable exoskeletons and robotic-assist devices. Their advanced technology and engineering have positioned them as a leader in the industry for over a decade. By providing innovative solutions for rehabilitation and industrial workers, Ekso Bionics enables individuals to surpass their current physical limitations and achieve new levels of mobility and strength. With a focus on strategic partnerships and cutting-edge innovation, Ekso Bionics remains at the forefront of the robotics field.Generated from the website

Diagnostica Stago is the exclusive provider of Diagnostica Stago hemostasis products in the United States. Diagnostica Stago offers a complete system of hemostasis instrumentation and optimized reagent kits for research as well as for routine analysis. A total quality approach plays an integral part in the corporate culture at Stago. The company is committed to a better understanding of hemostasis and thrombosis to provide clinical and research laboratories with the most advanced analyzer/reagent systems. In the United States, Diagnostica Stago has been servicing the clinical and research hemostasis laboratory community for more than 20 years with the same commitment to customers as Diagnostica Stago has maintained in Europe for the last 55 years.